UnknownNot Applicable

Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery

Denmark26 participantsStarted 2022-02-01

Plain-language summary

The primary objects of this study is to explore the potential effect of the autologous patch to optimize wound healing after skin cancer surgery with Mohs micrographic surgery (MMS) in the face in a randomized controlled trial comparing autologous patch healing versus secondary intention healing.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects undergoing MMS for biopsy verified primary nodular basal cell carcinoma in the face, head and neck area on a location suitable for secondary intention healing and thus may also be suitable for autologous patch healing
✓. Presenting relevant medical record report at study initiation
✓. Written informed consent obtained from subject
✓. Understanding of investigation procedures and willingness to abide to all procedures during the course of the investigation.

Exclusion criteria

✕. A subjects with major systemic disease not yet stabilized
✕. Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
✕. Pregnant or breast feeding
✕. Unable to follow the outlined study protocol
✕. Participation in other studies at the same time that may affect the wound healing.

What they're measuring

Blinded assesment of wound healing at day 18-20.

Timeframe: Day 18-20

Trial details

NCT IDNCT05170035

SponsorBispebjerg Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02

Contact for this trial

Katrine E Karmisholt, MD, PhD

+4561664351 katrine.elisabeth.karmisholt@regionh.dk

View on ClinicalTrials.gov More Skin Cancer trials